REG - Spire Healthcare Grp - Director/PDMR Shareholding
16/03/2022 08:15
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220316:nRSP9547Ea&default-theme=true
RNS Number : 9547E Spire Healthcare Group PLC 16 March 2022
Spire Healthcare Group plc
16 March 2022
Notification of Transactions of Persons Discharging Managerial
Responsibilities
This notification is made in accordance with DTR 3.1.4R (1) (a) of the
Disclosure and Transparency Rules.
Grant of Deferred Share Bonus Plan (DSBP) Awards
Spire Healthcare Group plc (the Company) announces that on 14 March 2022,
awards (the DSBP Awards) were granted over the Company's ordinary shares in
the form of nil-cost options to the Directors named below, under the Spire
Healthcare Group plc Deferred Share Bonus Plan.
Under the DSBP, Executive Directors are required to defer a proportion of
their gross cash bonus, received in respect of the full year ended 31 December
2021, into shares in the Company for a period of three years. The Directors
listed below have the following interest in shares as deferred share bonus
awards under the DSBP:
Director Percentage deferral of 2021 gross cash bonus* Deferred Shares
Justin Ash 50% 95,007
Jitesh Sodha 33% 47,420
* To be disclosed in the 2021 Annual Report and Accounts
The share price used to determine the number of Deferred Shares subject to
award was 238.5 pence, being the mid-market closing share price on 11 March
2022 (the dealing day prior to the awards being made).
The DSBP Awards will vest on the third anniversary of the grant date on 14
March 2025, subject to continued employment. Upon vesting, the options will
remain exercisable until 13 March 2032.
Grant of Long Term Incentive Plan (LTIP) awards
The Company further announces that, on 14 March 2022, a performance share
award was granted over the Company's ordinary shares in the form of nil cost
options to the following Executive Directors and PDMR in the Company, under
the rules of the Spire Healthcare Group plc Long Term Incentive Plan.
Executive Director Maximum number of shares
under Award
Justin Ash 543,750
Jitesh Sodha 365,853
Other PDMRs
John Forrest 207,221
Harbant Samra 57,007
The number of shares set out above represents 200% of each Executive
Director's base salary, 125% of John Forrest's base salary and 70% of Harbant
Samra's base salary. It is the maximum number which may vest under the LTIP
Awards following the end of the performance period (31 December 2024). The
shareholder-approved Remuneration Policy permits awards of up to 200% of base
salary.
The actual number of shares which vest will depend on the extent to which the
relevant performance conditions have been satisfied.
The performance conditions applicable to the LTIP Awards will be based as
follows:
· 35% on relative total shareholder return (TSR) performance;
· 35% on ROCE performance; and
· 30% on two Operational Excellence measures.
Further details of these performance conditions will be disclosed in the 2021
Annual Report and Accounts when published.
The share price used to determine the number of shares under the LTIP Awards
was 229.6 pence being the average of the mid-market closing share price over
the five trading days ending on 11 March 2022.
The transaction place is London.
Notes:
1) As previously disclosed, Justin Ash and Jitesh Sodha also hold
interests in awards granted under the DSBP during 2020 and 2021. Details of
these will be included in the Company's 2021 Annual Report and Accounts.
2) For Justin Ash, Jitesh Sodha and John Forrest the 2022 LTIP awards
described above will also be subject to a further two-year holding period
following the vesting date.
3) The actual number of shares which vest under the LTIP awards will
depend on the extent to which the relevant performance conditions are
satisfied in due course.
Name of contact and telephone number for queries:
Philip Davies
Company Secretary
Spire Healthcare Group plc
Tel: 07803 508348
Notification and public disclosure of transaction by persons discharging
managerial responsibility and persons closely associated with them
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Justin Ash
2 Reason for the notification
a) Position/status Chief Executive Officer/PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Grant of performance share awards under the Company's Deferred Share Bonus
Plan
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 95,007
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-03-14
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jitesh Sodha
2 Reason for the notification
a) Position/status Chief Financial Officer/PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Grant of performance share awards under the Company's Deferred Share Bonus
Plan
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 47,420
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-03-14
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Justin Ash
2 Reason for the notification
a) Position/status Chief Executive Officer/PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Grant of performance share awards under the Company's Long Term Incentive Plan
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 543,750
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-03-14
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jitesh Sodha
2 Reason for the notification
a) Position/status Chief Financial Officer/PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Grant of performance share awards under the Company's Long Term Incentive Plan
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 365,853
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-03-14
f) Place of the transaction XLON
a) Name John Forrest
2 Reason for the notification
a) Position/status Chief Operating Officer/PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Grant of performance share awards under the Company's Long Term Incentive Plan
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 207,221
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-03-14
f) Place of the transaction XLON
a) Name Harbant Samra
2 Reason for the notification
a) Position/status Interim Chief Financial Officer/PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Grant of performance share awards under the Company's Long Term Incentive Plan
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 57,007
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-03-14
f) Place of the transaction XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHGIGDXBGBDGDLRecent news on Spire Healthcare
See all newsREG - eEnergy Group PLC Spire Healthcare Grp - Major Contract Win with Spire Healthcare
AnnouncementREG - Spire Healthcare Grp - Capital Markets Event
AnnouncementREG - Spire Healthcare Grp - Notice of AGM
AnnouncementREG - Spire Healthcare Grp - Block listing Interim Review
AnnouncementREG - Spire Healthcare Grp - Portfolio management: Spire Tunbridge Wells
Announcement